4-(3-Bromo-4-fluorophenyl)-3-(4-nitro-1,2,5-oxadiazol-3-yl)-1,2,4-oxadiazol-5(4H)-one, 98%, 25g

Ethyl 2,3-Dicyanopropionate>98.0%(GC)25g

1-Methylcyclopropanecarboxamide, 95.0%, 250mg

8-BROMO-1,5-NAPHTHYRIDINE-3-CARBOXYLIC ACID, 95.0%, 250mg

3,3-Difluorocyclobutanecarboxylic acid, 95.0%, 50g

(1-Methyl-1H-pyrazol-3-yl)methanol, 95.0%, 5g

Brevianamide F, 97.0%, 25mg

ETHYL 3-CYANO-6-CHLORO-2-FLUOROBENZOATE, 95.0%, 1g

2-Hydroxy-5-nitro-3-(trifluoromethyl)pyridine, 98.0%, 100g

(2S,3S,4S,5R,6S)-6-{[4,6-dihydroxy-2-(4-hydroxyphenyl)-5-oxo-5H-chromen-7-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid, 95%, 1g

7-Methoxy-N-(3-(trifluoromethyl)phenyl)quinoline-4-carboxamide, 95.0%, 250mg

5-Methylindole-3-carboxylic acid methyl ester, 95.0%, 5g

2-(1,1-dimethylethyl)-4-(3-hydroxypropoxy)-6-(5-methoxy-2H-benzotriazol-2-yl)-phenol, 250mg